Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-9560
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism ; volume:21 ; number:1 ; day:2 ; month:2 ; year:2023 ; pages:1-14 ; date:12.2023
Thrombosis journal ; 21, Heft 1 (2.2.2023), 1-14, 12.2023
- Urheber
-
Song, Yijun
Yang, Dawei
Hou, Dongni
She, Jun
Song, Yuanlin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12959-023-00453-y
- URN
-
urn:nbn:de:101:1-2023040721032535214157
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Song, Yijun
- Yang, Dawei
- Hou, Dongni
- She, Jun
- Song, Yuanlin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
Effectiveness and safety of rivaroxaban or low-molecular-weight heparin in non-major orthopedic surgery: a meta-analysis of randomized controlled trials
Use of low-molecular-weight heparin in severe paraquat poisoning: a case report
Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration
Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
Low-molecular-weight heparin-induced skin necrosis without platelet fall: a case report in pregnancy
P‐Type Low‐Molecular‐Weight Hydrogelators
Heparin and Venous Thrombo-Embolism
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
Effectiveness and safety of rivaroxaban or low-molecular-weight heparin in non-major orthopedic surgery: a meta-analysis of randomized controlled trials
Use of low-molecular-weight heparin in severe paraquat poisoning: a case report
Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration
Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
Low-molecular-weight heparin-induced skin necrosis without platelet fall: a case report in pregnancy
P‐Type Low‐Molecular‐Weight Hydrogelators
Heparin and Venous Thrombo-Embolism
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
Effectiveness and safety of rivaroxaban or low-molecular-weight heparin in non-major orthopedic surgery: a meta-analysis of randomized controlled trials
Use of low-molecular-weight heparin in severe paraquat poisoning: a case report
Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration
Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
Low-molecular-weight heparin-induced skin necrosis without platelet fall: a case report in pregnancy
P‐Type Low‐Molecular‐Weight Hydrogelators